Understanding of latent tuberculosis, its treatment and treatment side effects in immigrant and refugee patients

被引:8
|
作者
Butcher K. [1 ]
Biggs B.-A. [1 ,2 ]
Leder K. [2 ,3 ]
Lemoh C. [1 ,2 ]
O'Brien D. [2 ,4 ]
Marshall C. [1 ,2 ]
机构
[1] Department of Medicine, University of Melbourne, Grattan St
[2] Victorian Infectious Diseases Service, Royal Melbourne Hospital, Grattan St, Parkville
[3] Department of Epidemiology and Preventive Medicine, Monash University, 99 Commercial Road, Melbourne
[4] Department of Infectious Diseases, Geelong Hospital, Bellerine Street, Geelong
关键词
Health literacy; Immigrant; Latent tuberculosis infection; Refugee;
D O I
10.1186/1756-0500-6-342
中图分类号
学科分类号
摘要
Background: Isoniazid treatment of latent tuberculosis infection (LTBI) is commonly prescribed in refugees and immigrants. We aimed to assess understanding of information provided about LTBI, its treatment and potential side effects. Methods. A questionnaire was administered in clinics at a tertiary hospital. Total Knowledge (TKS) and Total Side Effect Scores (TSES) were derived. Logistic regression analyses were employed to correlate socio-demographic factors with knowledge. Results: Fifty-two participants were recruited, 20 at isoniazid commencement and 32 already on isoniazid. The average TKS were 5.04/9 and 6.23/9 respectively and were significantly associated with interpreter use. Approximately half did not know how tuberculosis was transmitted. The average TSES were 5.0/7 and 3.5/7 respectively, but were not influenced by socio-demographic factors. Conclusions: There was suboptimal knowledge about LTBI. Improvements in health messages delivered via interpreters and additional methods of distributing information need to be developed for this patient population. © 2013 Butcher et al.; licensee BioMed Central Ltd.
引用
收藏
相关论文
共 50 条
  • [21] Treatment of Latent Tuberculosis Infection
    Dhar, Gauranga C.
    ANNALS OF INTERNAL MEDICINE, 2015, 162 (05) : 394 - 394
  • [22] Diagnosis and treatment of latent tuberculosis
    Nelson, Kenrad E.
    Hiransuthikul, Narin
    Hiransuthikul, Pornthip
    INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE, 2007, 11 (03) : 353 - 353
  • [23] Rifapentine for the treatment of latent tuberculosis
    Egelund, Eric F.
    Peloquin, Charles A.
    EXPERT REVIEW OF CLINICAL PHARMACOLOGY, 2016, 9 (10) : 1253 - 1261
  • [24] Treatment of latent tuberculosis infection
    Menzies, Dick
    Alvarez, Gonzalo G.
    Khan, Kamran
    CANADIAN RESPIRATORY JOURNAL, 2013, 20 : 44A - 53A
  • [25] Treatment of latent tuberculosis infection
    Meyer, BC
    NEW ENGLAND JOURNAL OF MEDICINE, 2003, 348 (13): : 1293 - 1293
  • [26] Treatment of latent tuberculosis infection
    Parekh, Madhavi J.
    Schluger, Neil W.
    THERAPEUTIC ADVANCES IN RESPIRATORY DISEASE, 2013, 7 (06) : 351 - 356
  • [27] Priorities for the treatment of latent tuberculosis
    Charles, M
    Rhee, KY
    NEW ENGLAND JOURNAL OF MEDICINE, 2004, 351 (08): : 832 - 833
  • [28] PATIENTS' PREFERENCES OVER TREATMENT SIDE-EFFECTS REFLECT A LATENT "OPTIMISM" CHARACTERISTIC
    Mukamel, D. B.
    Wenzel, L.
    Ladd, H.
    Osann, K.
    Sparks, L.
    Havrilesky, L.
    Wright, A. A.
    Walker, J.
    Robison, K.
    Alvarez, R.
    Van Le, L.
    Wakabayashi, M.
    Randall, L.
    Wahi, A.
    Hsieh, S.
    Lipscomb, J.
    Cohn, D.
    VALUE IN HEALTH, 2017, 20 (05) : A12 - A12
  • [29] Treatment of Latent Tuberculosis Infection in a Tuberculosis Clinic
    Angeles Jimenez-Fuentes, Maria
    Mila Auge, Celia
    Solsona Peiro, Jordi
    Luiza de Souza-Galvao, Maria
    ARCHIVOS DE BRONCONEUMOLOGIA, 2018, 54 (09): : 484 - 486
  • [30] Update on the treatment of tuberculosis and latent tuberculosis infection
    Blumberg, HM
    Leonard, MK
    Jasmer, RM
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2005, 293 (22): : 2776 - 2784